hydrocodone + acetaminophen (Teva Pharmaceutical)

TV-46763 is an immediate-release oral tablet formulation combining hydrocodone bitartrate and acetaminophen, developed by Teva Pharmaceutical for the management of moderate to severe pain. Hydrocodone is a semi-synthetic opioid agonist that binds to mu-opioid receptors in the central nervous system, inhibiting ascending pain pathways and altering the perception of pain. Acetaminophen is a non-opioid analgesic and antipyretic that is believed to act primarily by inhibiting prostaglandin synthesis in the central nervous system. The combination is intended to provide enhanced analgesia through complementary mechanisms of action, and it has been evaluated in Phase 3 clinical trials for postoperative pain following bunionectomy.

Other names

hydrocodone bitartrate + acetaminophen